scPRIME-seq uncovers synchronized multimodal molecular collapse facilitated by pre-neoplastic epigenetic burden in prostate cancer
Shengdi Li, Ziqun Liu, Yingying Xie, Xinan Wang, Hanchu Ye, Xingyong Ma, Ming Tan, Denglong Wu, 黄盛松, zhenfei li
The paper introduces scPRIME-seq, a multimodal single-cell platform, and finds pre-neoplastic epigenetic changes drive tumor progression in prostate cancer.
bioRxiv · Oct 9, 2026 · PreprintCancer Biology